LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.14
-0.10 (-1.38%)
At close: Mar 2, 2026, 4:00 PM EST
7.15
+0.01 (0.14%)
After-hours: Mar 2, 2026, 5:39 PM EST
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for LifeStance Health Group stock have an average target of 9.57, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 34.03% from the current stock price of 7.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LifeStance Health Group stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 2 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +40.06% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +68.07% | Feb 26, 2026 |
| Keybanc | Keybanc | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +26.05% | Feb 26, 2026 |
| BTIG | BTIG | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +54.06% | Feb 2, 2026 |
| BTIG | BTIG | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +40.06% | Dec 12, 2025 |
Financial Forecast
Revenue This Year
1.66B
from 1.42B
Increased by 16.27%
Revenue Next Year
1.89B
from 1.66B
Increased by 14.13%
EPS This Year
0.04
from 0.02
Increased by 112.52%
EPS Next Year
0.18
from 0.04
Increased by 312.77%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | 2.0B | |
| Avg | 1.7B | 1.9B | |
| Low | 1.6B | 1.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.9% | 19.7% | |
| Avg | 16.3% | 14.1% | |
| Low | 10.0% | 6.6% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.07 | 0.27 |
| Avg | 0.04 | 0.18 |
| Low | -0.01 | 0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 267.5% | 542.3% |
| Avg | 112.5% | 312.8% |
| Low | - | 38.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.